Maravai LifeSciences Holdings, Inc. Interest Expense Nonoperating
Maravai LifeSciences Holdings, Inc. (MRVI) reported Interest Expense Nonoperating of $4.81 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-07
- Maravai LifeSciences Holdings, Inc. interest expense nonoperating for the quarter ending 2026-06-30 was $4.81M, a 29.44% decline year-over-year.
- Maravai LifeSciences Holdings, Inc. interest expense nonoperating for the quarter ending 2026-03-31 was $5.75M, a 15.18% decline year-over-year.
- Maravai LifeSciences Holdings, Inc. interest expense nonoperating for the quarter ending 2025-12-31 was $6.55M, a 41.80% decline year-over-year.
- Maravai LifeSciences Holdings, Inc. interest expense nonoperating for the quarter ending 2025-09-30 was $6.84M, a 49.80% decline year-over-year.
- Maravai LifeSciences Holdings, Inc. interest expense nonoperating for fiscal 2025 was $26.99M, a 43.41% decline from fiscal 2024.
- Maravai LifeSciences Holdings, Inc. interest expense nonoperating for fiscal 2024 was $47.70M, a 3.94% increase from fiscal 2023.
- Maravai LifeSciences Holdings, Inc. interest expense nonoperating for fiscal 2023 was $45.89M, a 124.81% increase from fiscal 2022.
- Maravai LifeSciences Holdings, Inc. interest expense nonoperating for fiscal 2022 was $20.41M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.81M 10-Q · filed 2026-08-07 | $10.56M 10-Q · filed 2026-08-07 | $17.11M derived: sum of 3 quarters · filed 2026-08-07 | $23.96M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $5.75M 10-Q · filed 2026-05-08 | $12.30M derived: sum of 2 quarters · filed 2026-05-08 | $19.15M derived: sum of 3 quarters · filed 2026-05-08 | $25.96M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $6.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $13.40M derived: sum of 2 quarters · filed 2026-02-26 | $20.21M derived: sum of 3 quarters · filed 2026-08-07 | $26.99M 10-K · filed 2026-02-26 |
| 2025-09-30 | $6.84M 10-Q · filed 2025-11-07 | $13.66M derived: sum of 2 quarters · filed 2026-08-07 | $20.44M 10-Q · filed 2025-11-07 | $31.70M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $6.82M 10-Q · filed 2026-08-07 | $13.59M 10-Q · filed 2026-08-07 | $24.86M derived: sum of 3 quarters · filed 2026-08-07 | $38.49M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $6.78M 10-Q · filed 2026-05-08 | $18.04M derived: sum of 2 quarters · filed 2026-05-08 | $31.68M derived: sum of 3 quarters · filed 2026-05-08 | $43.61M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $11.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $24.90M derived: sum of 2 quarters · filed 2026-02-26 | $36.84M derived: sum of 3 quarters · filed 2026-02-26 | $47.70M 10-K · filed 2026-02-26 |
| 2024-09-30 | $13.63M 10-Q · filed 2025-11-07 | $25.57M derived: sum of 2 quarters · filed 2025-11-07 | $36.44M 10-Q · filed 2025-11-07 | $51.84M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $11.94M 10-Q · filed 2025-08-11 | $22.80M 10-Q · filed 2025-08-11 | $38.20M derived: sum of 3 quarters · filed 2026-02-26 | $49.84M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $10.86M 10-Q · filed 2025-05-12 | $26.26M derived: sum of 2 quarters · filed 2026-02-26 | $37.90M derived: sum of 3 quarters · filed 2026-02-26 | $44.92M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $15.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $27.04M derived: sum of 2 quarters · filed 2026-02-26 | $34.06M derived: sum of 3 quarters · filed 2026-02-26 | $45.89M 10-K · filed 2026-02-26 |
| 2023-09-30 | $11.64M 10-Q · filed 2024-11-12 | $18.66M derived: sum of 2 quarters · filed 2024-11-12 | $30.49M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $7.02M 10-Q · filed 2024-08-08 | $18.86M 10-Q · filed 2024-08-08 | ||
| 2022-12-31 | $20.41M 10-K · filed 2025-03-18 |